Business Acquisition (Details) $ / shares in Units, $ in Thousands, € in Millions			1 Months Ended	3 Months Ended		6 Months Ended
	Jun. 09, 2022 USD ($) $ / shares shares	Jun. 09, 2022 EUR (€) shares	Jun. 30, 2022 USD ($)	Jun. 30, 2022 USD ($)	Jun. 30, 2021 USD ($)	Jun. 30, 2022 USD ($)	Jun. 30, 2021 USD ($)
Business Acquisition [Line Items]
Total revenue				$ 74,136	$ 48,124	$ 190,010	$ 89,373
Net income (loss)				(9,450)	$ 3,612	34,608	$ 3,191
Acacia Pharma
Business Acquisition [Line Items]
Cash consideration	$ 77,971	€ 94.7
Cash consideration per share (in euros per share) | $ / shares	$ 0.90
Number of shares issued in business acquisition | shares	516,024	516,024
Cash paid per acquiree share | $ / shares	$ 0.68
Number of Company stock for each share of Acacia Pharma common stock converted | shares	0.0049	0.0049
Fair value of consideration	$ 101,616
Acquisition related expenses				$ 9,800		$ 11,300
Revenue from acquiree since acquisition			$ 200
Earnings (loss) from acquiree since acquisition			$ (3,400)